期刊名称：EUROPEAN JOURNAL OF GENERAL PRACTICE
|
ISSN： | 1381-4788
|
|
出版频率： | Quarterly
|
|
出版社： | TAYLOR & FRANCIS LTD, 2-4 PARK SQUARE, MILTON PARK, ABINGDON, England, OXON, OX14 4RN
|
|
出版社网址： | http://informahealthcare.com/loi/gen
| |
影响因子： | 1.904 |
| 主题范畴： | PRIMARY HEALTH CARE; MEDICINE, GENERAL & INTERNAL |
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The European Journal of General Practice (EJGP) is the official journal of WONCA Europe, the European Society of General Practice/Family Medicine.
The EJGP is an international, peer-reviewed scientific journal, established in 1995 and published in print (4 issues/year) and on line. It is indexed in Medline/PubMed and Embase.
The journal aims to:
- Foster scientific research in general practice/family medicine (GP/FM) and primary health care (PHC) in Europe, by the publication of original papers, short research reports and systematic reviews of the literature (‘evidence’), as well as papers on methodological issues.
- Stimulate education and debate relevant for the development of GP/FM in Europe by the publication of a variety of background papers, covering clinical matters, educational topics, or policy issues (‘using and discussing the evidence’).
- Facilitate the communication between the members of WONCA Europe, its international network organisations and special interest groups, national colleges and societies of GP/FM, academic departments and institutes, research networks, and individuals involved in research and teaching in GP/FM/PHC.
We appreciate contributions from disciplines outside family medicine, including health sciences and social sciences. Studies that contribute to our understanding of how social, cultural and environmental circumstances influence health differences between populations are welcome.
Priority will be given to high-quality original research that adds to our knowledge of clinical decision-making, health care management and organisation, medical education or research methodology. We particularly would like to encourage the reporting of studies that address issues formulated in the ‘Research Agenda for General Practice/Family Medicine and Primary Health Care in Europe’ (EGPRN 2009, available through www.egprn.org)
Abstracting & Indexing
Indexed/abstracted in: Index Medicus/MEDLINE; CAB Abstracts; Current Content/Clinical Medicine; EMBASE/Excerpta Medica; Science Citation Index Expanded; SciSearch; Scopus
Instructions to Authors
The European Journal of General Practice (EJGP) is the official journal of WONCA Europe, the European Society of General Practice/Family Medicine. The EJGP is an international, peer-reviewed scientific journal, established in 1995 and published in print (four issues/year) and on line. Members of the European General Practice Research Network (EGPRN) have free access to the online version of the Journal.
The Journal is included in the Science Citation Index Expanded and Current Contents/Clinical Medicine beginning with the first issue of 2009 (subject category ‘Primary health care’). The 2012 Journal Citations Report Impact Factor was 0.741. The EJGP is also indexed in Index Medicus/MEDLINE/PubMed, EMBASE/Excerpta Medica, Scopus, SciSearch and CAB Abstracts.
THE JOURNAL ACCEPTS THE FOLLOWING TYPES OF MANUSCRIPTS FOR CONSIDERATION:
- Research:
o Original research (quantitative, qualitative; IMRD-format; max. 2500 words)
o Research letter (short research report; IMRD-format, max. 1500 words)
o Systematic review of literature, incl. meta-analysis and meta-synthesis (max. 3000 words)
o Methodological paper (max. 2500 words)
- Education and debate:
o Clinical Lesson: systematic reflection on (a) clinical case(s) or situation(s) that general practitioners/family physicians could encounter in their work. A clinical lesson should have educational value, discuss available evidence and preferably lead to advice for practice or an idea for research (1500-2500 words)
o Background paper: like a non-systematic review of literature, executive summary of a (clinical) guideline, comment on a (clinical) guideline, article on medical education, report from an expert meeting, a position paper or other well-structured opinion paper relevant for the development of GP/FM and PHC (1500-3000 words)
o Short opinion paper: short, concisely formulated, well-structured article, preferably on a ‘hot topic’ or addressing ideas for research (max. 800 words)
o Letter to the Editor: short comment on an article that has recently been published in the EJGP, preferably adding new information (max. 500 words)
- News & Agenda (650 words/contribution, catchy title, maximum of two authors):
o News from WONCA Europe, its Network Organisations or Special Interest Groups
o News from WONCA Europe member organisations, relevant for a European audience
o News from GP/FM/PHC research groups and networks
o Announcements of (international) scientific conferences, (research) courses and other events for GPs/ family physicians, primary care researchers or teachers
o Short reports of (international) scientific conferences and (research) courses and other activities for GPs/ family physicians, primary care researchers or teachers
o Items for the Agenda
PEER REVIEW POLICY
All papers submitted to the EJGP are subject to peer review, except for the contributions to the ‘News and Agenda’ section. Papers that are outside the scope of the journal, that do not comply with the guidelines below, or are otherwise judged unsuitable by the Editor-in-Chief will be rejected without peer review. All other papers will be sent by one of the Editors to at least two peer reviewers. Authors are invited to suggest reviewers; the Editors of the Journal will consider such suggestions, but are free to seek referees of their own choice.
Reviewers advise on the originality and scientific merit of the paper and write a review report, including feedback to the author. Based on their reports, the responsible Associate Editor formulates a recommendation and the Editor-in-Chief finally decides on publication: rejection, reject and resubmit, major revision, minor revision, or (provisional or final) acceptance.
In all cases, the Editor-in-Chief, indicating acceptance or explaining the reasons for revision or rejection, will send an e-mail to the authors. Papers may be accepted subject to revision by the authors. If a paper is not resubmitted within three months, it will be considered as withdrawn and any new version will be treated as a new submission.
In its peer review process and publication policy, the EJGP will respect regional differences in health care systems, cultural backgrounds, and stages of societal and economic development. However, we will maintain the highest possible quality standards. We intend to complete the initial review round in 4-6 weeks.
LANGUAGE
The EJGP is published in the English language. Authors should write their contribution in British English. Consistent spelling should be used throughout the whole text, including Tables and Figures. NOTE: It is the responsibility of authors to ensure the quality of the language for submitted articles. Colloquial English may not be sufficient and is not necessarily the same as scientific English, for which professional services may be needed (see for example www.internationalscienceediting.com and www.writescienceright.com or other renowned editing services). A brief language overview will be carried out for articles accepted for publication, but no major changes are accepted at that stage (see also our note on author proofs below).
CONFLICT OF INTEREST AND FUNDING
Authors are responsible for recognising and disclosing financial and other conflicts of interest that might bias their work. They should acknowledge in the manuscript all financial support for the work and other financial or personal connections to the work.
ETHICS AND CONSENT
In all submitted papers, the authors should mention any necessary ethical approval (e.g. papers including (animal) experiments or clinical trials) by the local ethics committee. Please give the name of the body which gave approval, and date of issue and registration number where appropriate.
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients' names, initials, or hospital numbers, especially in illustrative material. Identifying information should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patients have been shown the manuscript to be published.
For a ‘Clinical lesson’, the authors might need to ask consent of the patient unless they are convinced this is not necessary. They should make an explicit statement on this issue in the article.
GUIDELINES FOR THE REPORTING OF MEDICAL RESEARCH
The Uniform Requirements for Manuscripts Submitted to Biomedical Journals can be found on the website of the International Committee for Medical Journal Editors (www.icmje.org ). We suggest authors to take good notice of existing guidelines on reporting of health research studies. A variety of guidelines and other supportive material can be found at the website of the Equator Network (www.equator-network.org ). NOTE: Our Editors and Reviewers will refer to these guidelines in their comments. The most relevant guidelines are:
- Randomised trials: the CONSORT statement (www.consort-statement.org . A flow diagram of subjects must be included in the paper and a numbered checklist must be provided as supplementary material. Please take good notice of the various extensions of the original guideline and choose the appropriate option (e.g. pragmatic trials, cluster randomized trials, etcetera).
- Diagnostic accuracy studies: the STARD statement (www.stard-statement.org .
- Observational studies: a variety of guidelines, including the STROBE statement (www.strobe-statement.org ) on epidemiological studies, and guidelines on surveys, case-control studies and case-reports, respectively.
- Systematic reviews: the PRISMA statement (www.prisma-statement.org ).
- For Qualitative Research, the Equator Network suggests the COREQ checklist (32 items). BMJ offers a practical check list and the EJGP published: Vermeire E, Van Royen P, Griffiths F, Coenen S, Peremans L, Hendrickx K. The critical appraisal of focus group research articles. Eur J Gen Pract 2002;8:104-8. (COREC: http://intqhc.oxfordjournals.org/content/19/6/349.long ; BMJ: http://resources.bmj.com/bmj/authors/checklists-forms/qualitative-research ; EJGP: http://informahealthcare.com/doi/abs/10.3109/13814780209160850 ).
PREPARATION OF MANUSCRIPTS
TYPOGRAPHY
Manuscripts should be complete in all aspects (see details below). The manuscript should be submitted as editable text files (MS Word). The text should be typed double-spaced, unjustified, and without hyphenation (except for compounded words). Enter only one space at the end of a sentence and after commas, semi-colons and colons. No space should be inserted before these punctuation marks. Use a margin of 2,5 cm around the page.
The text should be typed in Calibri font, 12 pt size. Title: bold font, 14 pt size; Section heading (heading level 1): 12 pt upper case (capital); Sub-headings (heading level 2): 12 pt italic upper and lower case, with the text beginning on the next line; Sub-sub-headings (heading level 3): 12 pt italic upper and lower case letters with the text continuing on the same line. Start a sentence with a number; write the number in full, as text (e.g Twenty-five, NOT 25). Numbers one to ten are written out in words unless they are used as a unit of measurement (e.g. five persons, but 5 mm Hg).
Tables should be created using the ‘insert table’ option of the text software (NOT by using the space bar or the tab key). To avoid misunderstanding by the copy editors, please make the grid of the table visible.
Abbreviations and symbols used must be standard and SI units used throughout. Acronyms should be used sparingly and must be fully explained when first used. Whenever possible, drugs should be given their approved generic name. When a proprietary (brand) name must be used, it should begin with a capital letter and the manufacturer’s address details should be given.
Check the final copy of your paper carefully.
Original Research Papers describing original research (quantitative, qualitative) should follow the Introduction-Methods-Results-Discussion (IMRD) format and should not exceed 2500 words. In general, they should contain no more than five tables or figures, and the number of references preferably should not exceed 30. Each section of the manuscript should start at a new page.
They should be arranged in the following order:
1. Title page, incl. acknowledgements, potential conflicts of interest and financial resources (to be saved and uploaded as a separate document file)
2. Abstract, Keywords and Key message
3. Introduction
4. Methods
5. Results
6. Discussion
7. Conclusion
8. References
9. Tables and Boxes
10. Figures (to be saved and uploaded as separate files, see further instructions below)
1. The Title page should be saved as a separate document file. The Title page(s) should bear: 1) the title of the paper; 2) the full names of the authors; 3) their affiliations; 4) their e-mail addresses; 5) the full postal address of the corresponding author; and 6) a running title (to be used for page heading when printed) of not more than 50 letters and spaces. This information (1-6) should ALSO be entered in separate boxes during the online submission process. In addition, personal acknowledgements, potential conflicts of interest and financial resources should be described on the Title page.
We prefer an informative Title. For research papers or systematic reviews, the title should summarize the main finding and preferably state the study population or setting and the study design. In case the paper describes an RCT, systematic review or qualitative study, the study design should be mentioned explicitly in the (sub) title. For other types of papers, the title should be a concise description of the main message of the article.
2. The Abstract should not exceed 250 words. The abstract should be concise and structured as follows: 1) Background, 2) Objectives, 3) Methods, 4) Results, 5) Conclusion. It should be written in a style that conveys the essential messages of all parts of the paper in abbreviated form.
Keywords: The author is required to select up to five keywords from the Keyword List in Manuscript Central for the purposes of indexing and retrieval. Please avoid adding your own ‘user keywords. The keywords should reflect the content of the paper. Furthermore, the keywords are important for matching editors and reviewers to your manuscript.
Key message: The author should provide 1-3 bulleted ‘take home’ messages (maximum of 50 words in total) which will be placed in a separate Box on the first page of the published article.
Abstract, Keywords and Key message should be included in the main manuscript file for the reviewers to consider, and ALSO as separate entries in the online manuscript submission system.
3. The Introduction should assume that the reader is knowledgeable in the field and provide a concise summary of what is already known of the topic under study. It should focus on the reasons to perform this particular study and should end with a clear study objective, research question or hypothesis to be tested.
4. In the Methods section, sub-headings should be used to structure this section, e.g. Study design, Selection of study subjects, Measurements or Qualitative methods, Outcomes and (Statistical) Analysis. Please follow existing guidelines for the reporting of medical research (see: www.equator-network.org ). Methods that have been published in detail elsewhere should not be described in detail again. Manuscripts that describe studies on humans must indicate that the study was approved by an institutional ethical review committee (provide name and registration number) and that the subjects gave informed consent. When appropriate, a trial registration number should be given.
5. In the Results section the actual Study population is described, followed by the Outcome(s) of the study. When appropriate, use sub-headings. Information given in Tables and Figures should not be replicated in the text, only be highlighted. Tables and Figures should be self-explanatory, i.e. not require information presented in the main text. In case of qualitative studies, the results should be grouped in appropriate paragraphs or text boxes. Only quotes that are most representative for the outcome they illustrate, should be given.
6. The Discussion section should be structured. It should contain a summary of the Main findings, a discussion of the Strengths and limitations of the present study, and an Interpretation of the study results in relation to existing literature. Finally, Implications for clinical practice, education, policy or research may be formulated.
7. The Conclusion should follow the Discussion section. It should provide a concise answer to the research objective(s) or question(s) formulated in the Introduction, or state whether the study hypothesis can be confirmed or rejected.
8. References: Only papers closely related to the present study should be quoted. Exhaustive lists should be avoided. In the text, they should appear as Arabic numerals within round brackets starting at (1) and be placed at the end of a sentence, before the dot, like this (2). or (3-5). or (8,11,13-15). At the end of the paper, references should be listed in the References section in numerical order corresponding to the order they are first mentioned in the text. References should follow the Vancouver format (see: www.nlm.nih.gov/bsd/uniform_requirements.html ). All authors should be quoted for papers with up to six authors; for papers with more than six authors, quote the first six followed by ‘et al’. Abbreviations for titles of medical periodicals should conform to those used in the latest edition of Index Medicus. The first and last page numbers for each reference must be provided (please note the examples below). Do NEITHER state issue numbers NOR issue dates or months. Abstracts and letters must be identified as such. Articles that have been accepted for publication but not have been published yet should be listed as ‘in press’, preferably followed by a DOI-number. Articles that have been submitted for publication but not have been accepted yet, should be described in the text as ‘personal communication’. Before submission, the references should be thoroughly checked (e.g. by using PubMed or Google).
Examples of the most common types of references:
- Journal article: Koorevaar R, Bruijnzeels MA, van der Wouden JC , van der Does E, van der Velden K, van Suijlekom LWA, et al. Patients suspect of meningitis. Eur J Gen Pract 1995;1:15-9.
- Chapter in a book: Moskowitz RW. Clinical and laboratory findings in osteoarthritis. In: McCarthy DJ, Koopman P, eds. Arthritis and allied conditions. 12th ed. London: Lea & Febiger, 1993:1735-60.
- Website: provide the URL and date of access, e.g. http://informahealthcare.com/journal/gen (accessed at <date>).
- For more details of the Vancouver style of referencing, please consult the uniform requirements for biomedical journals at http://www.ncbi.nlm.nih.gov/books/NBK7256 .
9. Tables and Boxes: These should be as few as possible and should present only essential data. Tables should be included with the ‘Insert Table’ tool in the text software. To avoid misunderstanding by the copy editors, please make the grid of the table visible. Tables should be included within the main manuscript file, after the References, each Table on a separate page, with a title or caption clearly marked, and an appropriate legend. Tables should be self-explanatory. Tables should be specifically referred to in the text using Arabic numerals e.g. (Table 3). Large tables, filing 1 or more pages, can also be saved and uploaded as separate document files. Summaries of qualitative studies can be provided by using text boxes, e.g. (Box 1) … (Box 2) etcetera.
10. Figures: Acceptable digital formats of figures are TIF, JPG, PDF, EPS, Microsoft Excel and PowerPoint. All figures should be specifically referred to in the text using Arabic numerals, e.g. (Figure 2). Lettering on figures should be noted in the legend and not in the figure image. The use of symbols should be explained in the caption, not on the figure. Like Tables, Figures should be self-explanatory. Each Figure should be uploaded as a separate file, and uploaded files should be named with the figure number. Line diagrams and graphs should be on separate pages; they must be supplied as digital files of a quality suitable for reproduction, i.e. at least 600 DPI. For photographs, image resolution needs to be at least 300 DPI. Images should be saved in CMYK colour.
Colour illustrations are free of charge in the online version of the journal. Please note that colour illustrations in print incur a cost of USD 1150. The colour charges are levied as a flat fee per article, one or 10 colour images can be included in the manuscript for the same price.
Details for other Manuscript Formats
Research letters are short original research reports. They should follow the IMRD format but should not exceed 1500 words. Abstract and Keywords should be provided. They should contain only 1-2 tables or figures, and the number of references preferably should not exceed 10. The number of heading levels used should be kept to a maximum of two.
Systematic reviews of literature, incl. meta-analyses and meta-syntheses, should follow the IMRD format and should not exceed 3000 words. Abstract and Keywords should be provided. Summary tables should be given. There is no limit to the number of references. When appropriate, the PRISMA statement (www.prisma-statement.org ) should be followed. A flow diagram showing the selection process of the included papers should be included in the manuscript as a Figure. The PRISMA checklist should be provided as supplementary material.
Methodological papers should follow a logical structure and should not exceed 2500 words. They should have an Abstract and Keywords.
Clinical Lessons are systematic reflections on clinical cases or situations that general practitioners/family physicians could encounter in their work. A ‘Clinical lesson’ should support the GP/FP’s clinical reasoning and decision-making. It should have an educational value by discussing available evidence (or the lack thereof) and preferably lead to an advice for daily practice or an idea for research. Therefore, we prefer ‘Clinical lessons’ that are (co-)authored by a GP/FP. Hospital specialists who have an idea for a ‘Clinical Lesson’ to be published in this Journal should be aware that we prefer cases that start in primary care.
Clinical lessons should contain an Introduction (explaining the reason for and the added value of the paper); a description of one (or more) Case(s) in as much detail as necessary, and a Discussion (of published literature incl. other case reports), leading to a Conclusion (e.g. an advice for daily practice, a supplement to a clinical guideline, a suggestion for education, or an idea for research, etc.). Clinical lessons should not exceed 2500 words and have a structured Abstract (Introduction-Case-Discussion-Conclusion) and Keywords.
For this type of paper, the authors might need to ask consent of the patient unless they are convinced this is not necessary. They should make an explicit statement on this issue in the article. An example of a ‘Clinical Lesson Consent Form’ (in English) is available from the Editorial Office or at http://mc.manuscriptcentral.com/ejgp under `Resources` (click ‘Instructions and forms`). Another option for this type of paper is a written contribution by the patient to the article (i.e. the patient as co-author).
Background papers, e.g. non-systematic reviews of literature, executive summaries of (clinical) guidelines, comments on (clinical) guidelines, articles on medical education, reports from expert meetings, position papers and other well-structured opinion papers relevant for the development of GP/FM and PHC, should follow a logical structure (e.g. Introduction, various paragraphs with a heading, Conclusion). An important criterion for acceptance of a ‘Background paper’ will be whether the paper adds something to existing knowledge of a topic (like implications for education, debate on policy, ideas for research, etc.). The length of a paper may vary between 1500- 3000 words. It should have an Abstract and Keywords.
A Series of background papers on a certain topic can be initiated by the Journal or be proposed by an author group.
Short opinion papers should be concisely formulated, well-structured essays preferably on ‘hot topics’ or addressing ideas for research. They should not exceed 800 words and the number of references normally will not exceed 5. They should have a short Abstract and a few Keywords.
Letters to the Editor are short comments on articles recently published in the EJGP, preferably adding new information. They should be submitted within 6 weeks after the original online issue publication, not exceed 500 words and contain only a few (maximum 3) references. Letters should be submitted with a clear article category heading ‘Letter to the Editor’. The authors should state to which article they refer (‘Comment on …’ or ‘Reply to …’). When submitting the manuscript in the online manuscript submission service, please provide a short summary of the Letter in the ‘Abstract’ field and mention the article the Letter comments on.
The Editorial Office will provide specific instructions for authors of Commentaries, Editorials and contributions to the ‘News & Agenda’ section of the Journal.
ONLINE SUBMISSION AND ACCEPTANCE OF MANUSCRIPTS
Manuscripts may only be submitted online via the EJGP ScholarOne Manuscripts site, a web-based manuscript submission and handling system. ScholarOne Manuscripts is accessible via http://mc.manuscriptcentral.com/ejgp.
Submitting authors new to the ScholarOne Manuscripts site should create an account at the start page. All submitting authors should upload manuscripts in the 'Author Centre'. All submissions will be acknowledged via e-mail stating the Manuscript ID number. This ID number must be referred to in the subject line of any correspondence with the Editorial Office. The current status of submitted manuscripts can be viewed via the Author Centre. If you have any problems submitting your manuscript, please contact the Editorial Office for further assistance.
The submitting author should prepare the following documents to be uploaded: a) Title page, b) Main manuscript (Abstract – Tables), c) separate files for each Figure (incl. photographs), and d) Supplementary files.
The submitting author should be aware that separate entries in the system (in addition to the details stated in the uploaded manuscript files) are required for: Title page, Abstract, Running title, Keywords, Key message, and Author data. For all authors full names, affiliations, and e-mail addresses should be provided, as well as the full postal address of the corresponding author. NOTE: ALL authors need to be registered in the system. They will receive a copy of the submission acknowledgement via e-mail.
A manuscript will be considered for publication on the understanding that it reports unpublished work or material that is not under consideration for publication elsewhere; that all named authors have agreed to its submission and have obtained permission from their employers or institution to publish if they have a contractual or moral obligation to do so; and that if accepted it will not later be published in the same or similar form in any language without the consent of the Publishers.
All submissions should be accompanied by a short letter indicating that the corresponding author takes full responsibility for the contents of the paper. Any special points to note for the Editor (e.g. on previous publications of the same study or data set) should also be emphasized in the covering letter. When appropriate, full publication details of an associated paper should be given, or a copy of a published paper should be uploaded.
Each revised or resubmitted manuscript should be accompanied by a point-to-point reply to the review comments.
SUPPLEMENTARY MATERIAL
The online manuscript submission and management system allows authors to upload supplementary material which they consider important for peer review or editorial judgment (e.g. additional or alternative tables, literature search strategies etc.). Furthermore, extra material, not to be published in print, could be requested to be placed on the Journal’s website, such as questionnaires, extensive data tables or other media that might not be included in the printed edition due to space restrictions. It is very important that the authors indicate adequately what documents (incl. captions and legends of tables and figures) are not to be printed, both when referring to the material in the main text as well as in the file designation when uploading the files.
PERMISSIONS
Authors should ensure that material copied from other sources is accompanied by clear written statements from the original author and publisher giving permission for the material to be reproduced in The European Journal of General Practice. It is the author's responsibility to ensure that permissions are obtained.
AUTHOR PROOFS – FINAL APPROVAL
Authors will be notified via e-mail when a manuscript is ready for final approval before publication. This e-mail provides instructions on how to log on to the online author service, where the final version of the manuscript can be downloaded as a printer ready PDF file.
To avoid delays of publication, proofs should be checked immediately and returned electronically through the online service, following the instructions given. Corrections submitted via the telephone or e-mail will NOT be accepted. Authors should be well aware that they are responsible for proof-reading of the text, references, tables and figures for absolute accuracy. Additional material or major corrections cannot be accepted at this stage, nor is substantial rewriting of paragraphs permitted. Such extensive changes may result in a delay or withdrawal of the article from publication. Any costs arising from major additional changes may also be charged to the authors.
COPYRIGHT
It is a condition of publication that authors assign copyright or license the publication rights of the contents of their articles, including abstracts, to Informa Healthcare. This enables full copyright protection and dissemination of the article and the Journal, to the widest possible readership in electronic and print formats. A document to verify this will be sent upon acceptance for publication.
This document should be signed by the corresponding author and returned to the Publisher for archiving. To read more about Informa Healthcare's policy and guidelines regarding copyright, please point your browser to the Copyright Transfer FAQ page.
EJGP Editorial Office
Address:
Maastricht University Medical Centre,
CAPHRI School for Public Health and Primary Care,
Department of General Practice/Family Medicine,
P.O. Box 616, 6200 MD Maastricht
The Netherlands
E-mail: ejgp-agermeraad@maastrichtuniversity.nl
Phone: +31 43 388 2213
Fax: +31 43 361 9344
Editorial Board
Editor-in-Chief: Dr Jelle Stoffers
EJGP Editorial Office address:
Maastricht University Medical Centre,
CAPHRI School for Public Health and Primary Care,
Department of General Practice/Family Medicine,
P.O. Box 616, 6200 MD Maastricht
The Netherlands
E-mail: ejgp-agermeraad@hag.unimaas.nl
Phone: +31 43 388 2213
Fax: +31 43 361 93 44
Office hours: Tuesday, Wednesday, Friday 08:30 to 17:00 CET
|
刊名字顺( Alphabetical List of Journals):
返回页首 